123 related articles for article (PubMed ID: 37774907)
1. Integrated analysis of tumour-derived exosome-related immune genes to predict progression and immune status of hepatocellular carcinoma.
Li W; Zhao B; Wang Q; Lu J; Wu X; Chen X
Clin Immunol; 2023 Nov; 256():109774. PubMed ID: 37774907
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.
Yang Z; Li X; Pan C; Li Y; Lin L; Jin Y; Zheng J; Yu Z
BMC Cancer; 2022 Dec; 22(1):1344. PubMed ID: 36550445
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-based prognostic modeling of lysosome-related genes for predicting prognosis and immune status of patients with hepatocellular carcinoma.
Li W; Wang Q; Lu J; Zhao B; Geng Y; Wu X; Chen X
Front Immunol; 2023; 14():1169256. PubMed ID: 37275878
[TBL] [Abstract][Full Text] [Related]
4. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma.
Du Z; Han X; Zhu L; Li L; Castellano L; Stebbing J; Peng L; Wang Z
BMC Med Genomics; 2024 Apr; 17(1):86. PubMed ID: 38627727
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
6. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
7. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
Gu X; Guan J; Xu J; Zheng Q; Chen C; Yang Q; Huang C; Wang G; Zhou H; Chen Z; Zhu H
J Transl Med; 2021 Jan; 19(1):26. PubMed ID: 33407546
[TBL] [Abstract][Full Text] [Related]
8. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
9. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
10. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
11. Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma.
Li T; Jiao J; Ke H; Ouyang W; Wang L; Pan J; Li X
Front Immunol; 2023; 14():1200201. PubMed ID: 37457718
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma.
Dong W; Xie Y; Huang H
Front Endocrinol (Lausanne); 2022; 13():884777. PubMed ID: 35733776
[TBL] [Abstract][Full Text] [Related]
13. Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma.
Zhang X; Zhuge J; Liu J; Xia Z; Wang H; Gao Q; Jiang H; Qu Y; Fan L; Ma J; Tan C; Luo W; Luo Y
Front Immunol; 2023; 14():1153423. PubMed ID: 37006285
[TBL] [Abstract][Full Text] [Related]
14. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
Front Immunol; 2022; 13():990790. PubMed ID: 36248822
[TBL] [Abstract][Full Text] [Related]
15. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma.
Li W; Wu R; Zhang S; Zhao Y; Li L; Hu Z; Su Q; Mang Y; Zhang X; Dong Y; Zheng K; Ran J; Li L
Clin Transl Oncol; 2023 Jul; 25(7):2099-2115. PubMed ID: 36708372
[TBL] [Abstract][Full Text] [Related]
16. Associating transcriptomics data with inflammatory markers to understand tumour microenvironment in hepatocellular carcinoma.
Bahcivanci B; Shafiha R; Gkoutos GV; Acharjee A
Cancer Med; 2023 Jan; 12(1):696-711. PubMed ID: 35715992
[TBL] [Abstract][Full Text] [Related]
17. An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
Zhang F; Cai J; Hu K; Liu W; Lu S; Tang B; Li M; Wu W; Ren Z; Yin X
Comb Chem High Throughput Screen; 2022; 25(13):2203-2216. PubMed ID: 35249477
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
[TBL] [Abstract][Full Text] [Related]
19. Exosome-transmitted circ_002136 promotes hepatocellular carcinoma progression by miR-19a-3p/RAB1A pathway.
Yuan P; Song J; Wang F; Chen B
BMC Cancer; 2022 Dec; 22(1):1284. PubMed ID: 36476239
[TBL] [Abstract][Full Text] [Related]
20. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
